APXZF (Carasent AB (publ)) Interest Expense: $-0.01 Mil (TTM As of Mar. 2026)

What is Carasent AB (publ) Interest Expense?

Carasent AB (publ) APXZF 80 Interest Expense is $-0.01 Mil as of Mar. 2026. GuruFocus rates APXZF with a GF Score™ of 80/100 and a GF Value™ of $0.18. The stock has 3 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Carasent AB (publ)'s interest expense for the three months ended in Mar. 2026 was $ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.01 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Carasent AB (publ)'s Operating Income for the three months ended in Mar. 2026 was $ 0.17 Mil. Carasent AB (publ)'s Interest Expense for the three months ended in Mar. 2026 was $ 0.00 Mil. GuruFocus does not calculate Carasent AB (publ)'s interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Carasent AB (publ) (OTCPK:APXZF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Carasent AB (publ)'s Interest Expense for the three months ended in Mar. 2026 was $0.00 Mil. Its Operating Income for the three months ended in Mar. 2026 was $0.17 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was $1.68 Mil.

Carasent AB (publ)'s Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

GuruFocus does not calculate Carasent AB (publ)'s interest coverage with the available data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Carasent AB (publ) has enough cash to cover all of its debt. Its financial situation is stable.

Carasent AB (publ) Interest Expense Historical Data

* Premium members only.

The historical data trend for Carasent AB (publ)'s Interest Expense can be seen below:

Carasent AB (publ) Interest Expense Chart

Carasent AB (publ) Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Interest Expense

Get a 7-Day Free Trial

-0.07

-0.13

-0.21

Carasent AB (publ) Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Interest Expense	Get a 7-Day Free Trial															-0.14	-0.01	0.00	0.00	0.00

80GF Score

Carasent AB (publ) APXZF

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Carasent AB (publ) Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of $-0.01 Mil mean?

Carasent AB (publ) (APXZF) has a Interest Expense of $-0.01 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Carasent AB (publ) and its competitors.

Is Carasent AB (publ)'s Interest Expense too high?

Carasent AB (publ)'s current Interest Expense is $-0.01 Mil. Overall, Carasent AB (publ) has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.

How does Carasent AB (publ)'s Interest Expense compare to VEEV and BTSG?

Carasent AB (publ)'s Interest Expense of $-0.01 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Healthcare Providers & Services company?

A good Interest Expense depends on the Healthcare Providers & Services industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Carasent AB (publ) and its competitors. Carasent AB (publ)'s current Interest Expense is $-0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Carasent AB (publ) stock overvalued right now?

Carasent AB (publ) (APXZF) has a current Interest Expense of $-0.01 Mil. The stock's GF Value™ is $0.18, compared to a current price of $0.15 — trading 16.7% below its estimated fair value. The current Interest Expense is $-0.01 Mil. Carasent AB (publ)'s overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For Carasent AB (publ) (APXZF), the current Interest Expense is $-0.01 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Carasent AB (publ) (APXZF) Overvalued in 2026?

Based on GuruFocus' analysis, Carasent AB (publ) stock appears to be undervalued. The current stock price of $0.15 is trading 16.7% below its estimated GF Value™ of $0.18.

Key valuation signals for APXZF:

Interest Expense: $-0.01 Mil
GF Value™: $0.18 vs. price of $0.15 (16.7% below fair value)
GF Score™: 80/100 with 3 warning signs

No single metric tells the full story. See the APXZF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Carasent AB (publ) Business Description

Industry Healthcare Healthcare Providers & Services

Comparable Companies OSTO:SUS NGM:H100 OSTO:PTRK XSAT:SYNT XSAT:KONT OSTO:AINO OSTO:RAY B VEEV ASX:PME BTSG TEM HQY TSE:2413 HNGE TXG DOCS WAY HKSE:02228 PRVA HTFL

Other Exchanges CARA:Sweden E0C:Germany

Address Nellickevagen 24C, Gothenburg, NOR, 412 63

Website https://www.carasent.com

Carasent AB (publ) Formerly Carasent AB is a comprehensive provider of cloudbased EHR solutions and platform services for various organizations within the healthcare sector. With Webdoc as the main product, the group offers a broad ecosystem of services, including solutions for patient communication and business intelligence. Geographically, the company operates in the Nordic region and Germany. It derives maximum revenue from Nordic Region. The solutions provides by the group are: Webdoc; Metodika; Medrave; HPI plustoo; Ad Curis; Ad Opus; Webcur; Data-AL; and Data-Cur.

80GF Score

Get the complete analysis for APXZF

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.15

Price

$0.18

GF Value

View APXZF Analysis

See Interest Expense data for all stocks →